# Regulation of glial markers expression in the rat basolateral amygdala and hippocampus during morphine aversive memory retrieval and its extinction

**Authors:** Aurelio Franco-García, Victoria Gómez-Murcia, Cristina Núñez

PMC · DOI: 10.1186/s12993-025-00313-x · Behavioral and Brain Functions : BBF · 2025-12-14

## TL;DR

This study explores how glial cells in the rat brain change during morphine withdrawal and extinction therapy, suggesting they may play a role in relapse prevention.

## Contribution

The study reveals microglial activity in the hippocampus during morphine aversive memory retrieval and extinction.

## Key findings

- Microglial markers in the CA1 region were downregulated during aversive memory retrieval and restored after extinction.
- The microglial marker klf4 was reduced during extinction memory retrieval in the dentate gyrus.
- Negative correlations were found between microglial markers and aversive memory strength.

## Abstract

Opioid use disorder is driven by neurobehavioral adaptations where environmental cues trigger relapse. Consequently, extinction therapy (ET) aims to modify drug-associated memories but has limited long-term efficacy. Recently, evidence suggested that glial cells may contribute to neuroplasticity phenomena in addiction. In this sense, this study examined whether aversive memories of morphine withdrawal and their extinction induce transcriptional changes in glial markers (gfap, aif1, itgam, klf4) in key memory-related regions: the basolateral amygdala (BLA) and hippocampus (dentate gyrus [DG] and CA1).

Using the conditioned place aversion (CPA) paradigm in rats, we assessed avoidance behavior after naloxone-precipitated withdrawal and its extinction. Transcriptional analyses did not reveal major changes in the BLA. However, in CA1, downregulation of microglial markers cooccurred with aversive memory retrieval and restored after extinction. Moreover, one of the microglial markers, klf4, was reduced concomitantly with extinction memory retrieval in the DG. Correlation analyses showed negative associations between microglial markers and aversive memory strength, suggesting glial involvement in withdrawal-related learning.

These findings might indicate that microglial activity in CA1 plays a role in opioid withdrawal-associated memories, and extinction training might be returning these effects to basal levels. Therefore, targeting glial responses could provide new therapeutic strategies to prevent relapse.

The online version contains supplementary material available at 10.1186/s12993-025-00313-x.

## Linked entities

- **Genes:** GFAP (glial fibrillary acidic protein) [NCBI Gene 2670], AIF1 (allograft inflammatory factor 1) [NCBI Gene 199], ITGAM (integrin subunit alpha M) [NCBI Gene 3684], KLF4 (KLF transcription factor 4) [NCBI Gene 9314]
- **Chemicals:** morphine (PubChem CID 5288826), naloxone (PubChem CID 4425)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Klf4 (KLF transcription factor 4) [NCBI Gene 114505] {aka GKLF}, Gfap (glial fibrillary acidic protein) [NCBI Gene 24387], Itgam (integrin subunit alpha M) [NCBI Gene 25021] {aka Cd11b}, Aif1 (allograft inflammatory factor 1) [NCBI Gene 29427] {aka BART-1, Bart1, iba1, mrf-1}
- **Diseases:** Opioid use disorder (MESH:D009293)
- **Chemicals:** morphine (MESH:D009020), naloxone (MESH:D009270)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12821304/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12821304/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12821304/full.md

---
Source: https://tomesphere.com/paper/PMC12821304